Global Bioresorbable Scaffolds

Bioresorbable Scaffolds Comprehensive Study by Type (Synthetic, Biological), Application (Coronary Artery Stents, Peripheral Artery Stents, Others), Material (Metal-based Bioresorbable Scaffold, Polymer-based Bioresorbable Scaffold), End User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Others) Players and Region - Global Market Outlook to 2028

Bioresorbable Scaffolds Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 11.89%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Bioresorbable Scaffolds
Growing incidence of cardiovascular diseases coronary, heart disease and ischaemic heart disease will help to boost the bioresorbable scaffolds market all over the world in the anticipated period. Bioresorbable scaffolds are the medical devices used during surgeries. Bioresorbable scaffolds are preferred over permanent implantation as they decrease device/host interaction, and requirement for long-term anti-coagulation therapy. Growing preference for vascular graft devices for angioplasty and coronary artery diseases is major factor driving bioresorbable scaffolds market.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR11.89%


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.The Players having a strong hold in the market are 480 Biomedical, Abbott Laboratories, Amaranth Medical, Arterial Remodeling Technologies, and Arterius. Analyst at AMA Research estimates that United States and Chinese Players will contribute the maximum growth to Global Bioresorbable Scaffolds market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

480 Biomedical (United States), Abbott Laboratories (United States), Amaranth Medical Inc. (Singapore), Arterial Remodeling Technologies (France), Arterius Limited (United Kingdom), BIOTRONIK (Germany), Boston Scientific Corporation (United States), Elixir Medical Corporation (United States), HangZhou HuaAn Biotechnology Co. Ltd. (China) and KYOTO MEDICAL PLANNING Co. Ltd. (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Lepu Medical Technology (Beijing) Co., Ltd. (China), Lifetech Scientific (Shenzhen) Co. Ltd (China), Manli Cardiology Ltd. (United States), Meril Life Sciences Pvt. Ltd. (India), OrbusNeich (hong Kong), Qualimed S.A.S. (France) and REVA Medical Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Bioresorbable Scaffolds market by Type (Synthetic and Biological), Application (Coronary Artery Stents, Peripheral Artery Stents and Others) and Region.



On the basis of geography, the market of Bioresorbable Scaffolds has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North Amercia region held largest market share in the year 2022. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Material, the sub-segment i.e. Metal-based Bioresorbable Scaffold will boost the Bioresorbable Scaffolds market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Bioresorbable Scaffolds market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Introduction Preference for Vascular Graft Devices for Angioplasty and Coronary Artery Diseases and Growing Adoption of Minimally Invasive Cardio Vascular Treatments

Market Growth Drivers:
Rising Prevalence of Coronary Heart Disease and Ischemic Heart Disease and Growing Applications of Bioresorbable Stents by Physicians and Patients

Challenges:
Introduction to New Players and Technological Existing is Viable to Threat of New Entrants and Stringent Government Regulations related to Bioresorbable Scaffolds

Restraints:
Skilled Physicians or Hospital Staff is required and Lack of Healthcare Infrastructure and Ongoing Advancements in Underdeveloped Economies

Opportunities:
Upsurging Funding for Research and Development of Surgical Procedures and Unfavorable Lifestyle Changes causing Obesity and Fatigue

Market Leaders and their expansionary development strategies
On February 20, 2019, Abbott and Novo Nordisk have formed a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system. The partnership reflects both companies′ commitment to make diabetes management easier by connecting key technologies such as continuous glucose monitoring (CGM) and connected insulin pens.



Key Target Audience
Bioresorbable Scaffolds Manufacturers, Bioresorbable Scaffolds Distributors and Traders, Hospitals and Clinics, Healthcare Industrial Associations, Government Agencies, Research and Development Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Synthetic
  • Biological
By Application
  • Coronary Artery Stents
  • Peripheral Artery Stents
  • Others
By Material
  • Metal-based Bioresorbable Scaffold
  • Polymer-based Bioresorbable Scaffold

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Coronary Heart Disease and Ischemic Heart Disease
      • 3.2.2. Growing Applications of Bioresorbable Stents by Physicians and Patients
    • 3.3. Market Challenges
      • 3.3.1. Introduction to New Players and Technological Existing is Viable to Threat of New Entrants
      • 3.3.2. Stringent Government Regulations related to Bioresorbable Scaffolds
    • 3.4. Market Trends
      • 3.4.1. Introduction Preference for Vascular Graft Devices for Angioplasty and Coronary Artery Diseases
      • 3.4.2. Growing Adoption of Minimally Invasive Cardio Vascular Treatments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bioresorbable Scaffolds, by Type, Application, Material, End User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Bioresorbable Scaffolds (Value)
      • 5.2.1. Global Bioresorbable Scaffolds by: Type (Value)
        • 5.2.1.1. Synthetic
        • 5.2.1.2. Biological
      • 5.2.2. Global Bioresorbable Scaffolds by: Application (Value)
        • 5.2.2.1. Coronary Artery Stents
        • 5.2.2.2. Peripheral Artery Stents
        • 5.2.2.3. Others
      • 5.2.3. Global Bioresorbable Scaffolds by: Material (Value)
        • 5.2.3.1. Metal-based Bioresorbable Scaffold
        • 5.2.3.2. Polymer-based Bioresorbable Scaffold
      • 5.2.4. Global Bioresorbable Scaffolds by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ambulatory Surgical Centers
        • 5.2.4.3. Cardiac Centers
        • 5.2.4.4. Others
      • 5.2.5. Global Bioresorbable Scaffolds Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Bioresorbable Scaffolds (Volume)
      • 5.3.1. Global Bioresorbable Scaffolds by: Type (Volume)
        • 5.3.1.1. Synthetic
        • 5.3.1.2. Biological
      • 5.3.2. Global Bioresorbable Scaffolds by: Application (Volume)
        • 5.3.2.1. Coronary Artery Stents
        • 5.3.2.2. Peripheral Artery Stents
        • 5.3.2.3. Others
      • 5.3.3. Global Bioresorbable Scaffolds by: Material (Volume)
        • 5.3.3.1. Metal-based Bioresorbable Scaffold
        • 5.3.3.2. Polymer-based Bioresorbable Scaffold
      • 5.3.4. Global Bioresorbable Scaffolds by: End User (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Ambulatory Surgical Centers
        • 5.3.4.3. Cardiac Centers
        • 5.3.4.4. Others
      • 5.3.5. Global Bioresorbable Scaffolds Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Bioresorbable Scaffolds (Price)
      • 5.4.1. Global Bioresorbable Scaffolds by: Type (Price)
  • 6. Bioresorbable Scaffolds: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 480 Biomedical (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Amaranth Medical Inc. (Singapore)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Arterial Remodeling Technologies (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Arterius Limited (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BIOTRONIK (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Elixir Medical Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. HangZhou HuaAn Biotechnology Co. Ltd. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. KYOTO MEDICAL PLANNING Co. Ltd. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Bioresorbable Scaffolds Sale, by Type, Application, Material, End User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Bioresorbable Scaffolds (Value)
      • 7.2.1. Global Bioresorbable Scaffolds by: Type (Value)
        • 7.2.1.1. Synthetic
        • 7.2.1.2. Biological
      • 7.2.2. Global Bioresorbable Scaffolds by: Application (Value)
        • 7.2.2.1. Coronary Artery Stents
        • 7.2.2.2. Peripheral Artery Stents
        • 7.2.2.3. Others
      • 7.2.3. Global Bioresorbable Scaffolds by: Material (Value)
        • 7.2.3.1. Metal-based Bioresorbable Scaffold
        • 7.2.3.2. Polymer-based Bioresorbable Scaffold
      • 7.2.4. Global Bioresorbable Scaffolds by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ambulatory Surgical Centers
        • 7.2.4.3. Cardiac Centers
        • 7.2.4.4. Others
      • 7.2.5. Global Bioresorbable Scaffolds Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Bioresorbable Scaffolds (Volume)
      • 7.3.1. Global Bioresorbable Scaffolds by: Type (Volume)
        • 7.3.1.1. Synthetic
        • 7.3.1.2. Biological
      • 7.3.2. Global Bioresorbable Scaffolds by: Application (Volume)
        • 7.3.2.1. Coronary Artery Stents
        • 7.3.2.2. Peripheral Artery Stents
        • 7.3.2.3. Others
      • 7.3.3. Global Bioresorbable Scaffolds by: Material (Volume)
        • 7.3.3.1. Metal-based Bioresorbable Scaffold
        • 7.3.3.2. Polymer-based Bioresorbable Scaffold
      • 7.3.4. Global Bioresorbable Scaffolds by: End User (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Ambulatory Surgical Centers
        • 7.3.4.3. Cardiac Centers
        • 7.3.4.4. Others
      • 7.3.5. Global Bioresorbable Scaffolds Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Bioresorbable Scaffolds (Price)
      • 7.4.1. Global Bioresorbable Scaffolds by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bioresorbable Scaffolds: by Type(USD Million)
  • Table 2. Bioresorbable Scaffolds Synthetic , by Region USD Million (2017-2022)
  • Table 3. Bioresorbable Scaffolds Biological , by Region USD Million (2017-2022)
  • Table 4. Bioresorbable Scaffolds: by Application(USD Million)
  • Table 5. Bioresorbable Scaffolds Coronary Artery Stents , by Region USD Million (2017-2022)
  • Table 6. Bioresorbable Scaffolds Peripheral Artery Stents , by Region USD Million (2017-2022)
  • Table 7. Bioresorbable Scaffolds Others , by Region USD Million (2017-2022)
  • Table 8. Bioresorbable Scaffolds: by Material(USD Million)
  • Table 9. Bioresorbable Scaffolds Metal-based Bioresorbable Scaffold , by Region USD Million (2017-2022)
  • Table 10. Bioresorbable Scaffolds Polymer-based Bioresorbable Scaffold , by Region USD Million (2017-2022)
  • Table 11. Bioresorbable Scaffolds: by End User(USD Million)
  • Table 12. Bioresorbable Scaffolds Hospitals , by Region USD Million (2017-2022)
  • Table 13. Bioresorbable Scaffolds Ambulatory Surgical Centers , by Region USD Million (2017-2022)
  • Table 14. Bioresorbable Scaffolds Cardiac Centers , by Region USD Million (2017-2022)
  • Table 15. Bioresorbable Scaffolds Others , by Region USD Million (2017-2022)
  • Table 16. South America Bioresorbable Scaffolds, by Country USD Million (2017-2022)
  • Table 17. South America Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 18. South America Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 19. South America Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 20. South America Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 21. Brazil Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 22. Brazil Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 23. Brazil Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 24. Brazil Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 25. Argentina Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 26. Argentina Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 27. Argentina Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 28. Argentina Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 29. Rest of South America Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 31. Rest of South America Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 32. Rest of South America Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 33. Asia Pacific Bioresorbable Scaffolds, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 36. Asia Pacific Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 37. Asia Pacific Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 38. China Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 39. China Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 40. China Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 41. China Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 42. Japan Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 43. Japan Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 44. Japan Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 45. Japan Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 46. India Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 47. India Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 48. India Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 49. India Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 50. South Korea Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 51. South Korea Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 52. South Korea Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 53. South Korea Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 54. Taiwan Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 55. Taiwan Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 56. Taiwan Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 57. Taiwan Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 58. Australia Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 59. Australia Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 60. Australia Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 61. Australia Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 66. Europe Bioresorbable Scaffolds, by Country USD Million (2017-2022)
  • Table 67. Europe Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 68. Europe Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 69. Europe Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 70. Europe Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 71. Germany Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 72. Germany Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 73. Germany Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 74. Germany Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 75. France Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 76. France Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 77. France Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 78. France Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 79. Italy Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 80. Italy Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 81. Italy Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 82. Italy Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 83. United Kingdom Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 84. United Kingdom Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 85. United Kingdom Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 86. United Kingdom Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 87. Netherlands Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 88. Netherlands Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 89. Netherlands Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 90. Netherlands Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 91. Rest of Europe Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 92. Rest of Europe Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 93. Rest of Europe Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 94. Rest of Europe Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 95. MEA Bioresorbable Scaffolds, by Country USD Million (2017-2022)
  • Table 96. MEA Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 97. MEA Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 98. MEA Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 99. MEA Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 100. Middle East Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 101. Middle East Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 102. Middle East Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 103. Middle East Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 104. Africa Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 105. Africa Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 106. Africa Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 107. Africa Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 108. North America Bioresorbable Scaffolds, by Country USD Million (2017-2022)
  • Table 109. North America Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 110. North America Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 111. North America Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 112. North America Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 113. United States Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 114. United States Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 115. United States Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 116. United States Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 117. Canada Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 118. Canada Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 119. Canada Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 120. Canada Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 121. Mexico Bioresorbable Scaffolds, by Type USD Million (2017-2022)
  • Table 122. Mexico Bioresorbable Scaffolds, by Application USD Million (2017-2022)
  • Table 123. Mexico Bioresorbable Scaffolds, by Material USD Million (2017-2022)
  • Table 124. Mexico Bioresorbable Scaffolds, by End User USD Million (2017-2022)
  • Table 125. Bioresorbable Scaffolds Sales: by Type(K Units)
  • Table 126. Bioresorbable Scaffolds Sales Synthetic , by Region K Units (2017-2022)
  • Table 127. Bioresorbable Scaffolds Sales Biological , by Region K Units (2017-2022)
  • Table 128. Bioresorbable Scaffolds Sales: by Application(K Units)
  • Table 129. Bioresorbable Scaffolds Sales Coronary Artery Stents , by Region K Units (2017-2022)
  • Table 130. Bioresorbable Scaffolds Sales Peripheral Artery Stents , by Region K Units (2017-2022)
  • Table 131. Bioresorbable Scaffolds Sales Others , by Region K Units (2017-2022)
  • Table 132. Bioresorbable Scaffolds Sales: by Material(K Units)
  • Table 133. Bioresorbable Scaffolds Sales Metal-based Bioresorbable Scaffold , by Region K Units (2017-2022)
  • Table 134. Bioresorbable Scaffolds Sales Polymer-based Bioresorbable Scaffold , by Region K Units (2017-2022)
  • Table 135. Bioresorbable Scaffolds Sales: by End User(K Units)
  • Table 136. Bioresorbable Scaffolds Sales Hospitals , by Region K Units (2017-2022)
  • Table 137. Bioresorbable Scaffolds Sales Ambulatory Surgical Centers , by Region K Units (2017-2022)
  • Table 138. Bioresorbable Scaffolds Sales Cardiac Centers , by Region K Units (2017-2022)
  • Table 139. Bioresorbable Scaffolds Sales Others , by Region K Units (2017-2022)
  • Table 140. South America Bioresorbable Scaffolds Sales, by Country K Units (2017-2022)
  • Table 141. South America Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 142. South America Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 143. South America Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 144. South America Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 145. Brazil Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 146. Brazil Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 147. Brazil Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 148. Brazil Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 149. Argentina Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 150. Argentina Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 151. Argentina Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 152. Argentina Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 153. Rest of South America Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 154. Rest of South America Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 155. Rest of South America Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 156. Rest of South America Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 157. Asia Pacific Bioresorbable Scaffolds Sales, by Country K Units (2017-2022)
  • Table 158. Asia Pacific Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 159. Asia Pacific Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 160. Asia Pacific Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 161. Asia Pacific Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 162. China Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 163. China Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 164. China Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 165. China Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 166. Japan Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 167. Japan Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 168. Japan Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 169. Japan Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 170. India Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 171. India Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 172. India Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 173. India Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 174. South Korea Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 175. South Korea Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 176. South Korea Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 177. South Korea Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 178. Taiwan Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 179. Taiwan Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 180. Taiwan Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 181. Taiwan Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 182. Australia Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 183. Australia Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 184. Australia Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 185. Australia Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 186. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 187. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 188. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 189. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 190. Europe Bioresorbable Scaffolds Sales, by Country K Units (2017-2022)
  • Table 191. Europe Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 192. Europe Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 193. Europe Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 194. Europe Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 195. Germany Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 196. Germany Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 197. Germany Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 198. Germany Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 199. France Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 200. France Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 201. France Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 202. France Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 203. Italy Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 204. Italy Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 205. Italy Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 206. Italy Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 207. United Kingdom Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 208. United Kingdom Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 209. United Kingdom Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 210. United Kingdom Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 211. Netherlands Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 212. Netherlands Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 213. Netherlands Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 214. Netherlands Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 215. Rest of Europe Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 216. Rest of Europe Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 217. Rest of Europe Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 218. Rest of Europe Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 219. MEA Bioresorbable Scaffolds Sales, by Country K Units (2017-2022)
  • Table 220. MEA Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 221. MEA Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 222. MEA Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 223. MEA Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 224. Middle East Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 225. Middle East Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 226. Middle East Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 227. Middle East Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 228. Africa Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 229. Africa Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 230. Africa Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 231. Africa Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 232. North America Bioresorbable Scaffolds Sales, by Country K Units (2017-2022)
  • Table 233. North America Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 234. North America Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 235. North America Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 236. North America Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 237. United States Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 238. United States Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 239. United States Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 240. United States Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 241. Canada Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 242. Canada Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 243. Canada Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 244. Canada Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 245. Mexico Bioresorbable Scaffolds Sales, by Type K Units (2017-2022)
  • Table 246. Mexico Bioresorbable Scaffolds Sales, by Application K Units (2017-2022)
  • Table 247. Mexico Bioresorbable Scaffolds Sales, by Material K Units (2017-2022)
  • Table 248. Mexico Bioresorbable Scaffolds Sales, by End User K Units (2017-2022)
  • Table 249. Bioresorbable Scaffolds: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Bioresorbable Scaffolds: by Type(USD Million)
  • Table 261. Bioresorbable Scaffolds Synthetic , by Region USD Million (2023-2028)
  • Table 262. Bioresorbable Scaffolds Biological , by Region USD Million (2023-2028)
  • Table 263. Bioresorbable Scaffolds: by Application(USD Million)
  • Table 264. Bioresorbable Scaffolds Coronary Artery Stents , by Region USD Million (2023-2028)
  • Table 265. Bioresorbable Scaffolds Peripheral Artery Stents , by Region USD Million (2023-2028)
  • Table 266. Bioresorbable Scaffolds Others , by Region USD Million (2023-2028)
  • Table 267. Bioresorbable Scaffolds: by Material(USD Million)
  • Table 268. Bioresorbable Scaffolds Metal-based Bioresorbable Scaffold , by Region USD Million (2023-2028)
  • Table 269. Bioresorbable Scaffolds Polymer-based Bioresorbable Scaffold , by Region USD Million (2023-2028)
  • Table 270. Bioresorbable Scaffolds: by End User(USD Million)
  • Table 271. Bioresorbable Scaffolds Hospitals , by Region USD Million (2023-2028)
  • Table 272. Bioresorbable Scaffolds Ambulatory Surgical Centers , by Region USD Million (2023-2028)
  • Table 273. Bioresorbable Scaffolds Cardiac Centers , by Region USD Million (2023-2028)
  • Table 274. Bioresorbable Scaffolds Others , by Region USD Million (2023-2028)
  • Table 275. South America Bioresorbable Scaffolds, by Country USD Million (2023-2028)
  • Table 276. South America Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 277. South America Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 278. South America Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 279. South America Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 280. Brazil Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 281. Brazil Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 282. Brazil Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 283. Brazil Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 284. Argentina Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 285. Argentina Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 286. Argentina Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 287. Argentina Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 288. Rest of South America Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 289. Rest of South America Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 290. Rest of South America Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 291. Rest of South America Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 292. Asia Pacific Bioresorbable Scaffolds, by Country USD Million (2023-2028)
  • Table 293. Asia Pacific Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 294. Asia Pacific Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 295. Asia Pacific Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 296. Asia Pacific Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 297. China Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 298. China Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 299. China Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 300. China Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 301. Japan Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 302. Japan Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 303. Japan Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 304. Japan Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 305. India Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 306. India Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 307. India Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 308. India Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 309. South Korea Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 310. South Korea Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 311. South Korea Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 312. South Korea Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 313. Taiwan Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 314. Taiwan Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 315. Taiwan Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 316. Taiwan Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 317. Australia Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 318. Australia Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 319. Australia Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 320. Australia Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 321. Rest of Asia-Pacific Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 322. Rest of Asia-Pacific Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 323. Rest of Asia-Pacific Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 324. Rest of Asia-Pacific Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 325. Europe Bioresorbable Scaffolds, by Country USD Million (2023-2028)
  • Table 326. Europe Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 327. Europe Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 328. Europe Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 329. Europe Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 330. Germany Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 331. Germany Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 332. Germany Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 333. Germany Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 334. France Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 335. France Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 336. France Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 337. France Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 338. Italy Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 339. Italy Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 340. Italy Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 341. Italy Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 342. United Kingdom Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 343. United Kingdom Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 344. United Kingdom Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 345. United Kingdom Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 346. Netherlands Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 347. Netherlands Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 348. Netherlands Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 349. Netherlands Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 350. Rest of Europe Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 351. Rest of Europe Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 352. Rest of Europe Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 353. Rest of Europe Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 354. MEA Bioresorbable Scaffolds, by Country USD Million (2023-2028)
  • Table 355. MEA Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 356. MEA Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 357. MEA Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 358. MEA Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 359. Middle East Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 360. Middle East Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 361. Middle East Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 362. Middle East Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 363. Africa Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 364. Africa Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 365. Africa Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 366. Africa Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 367. North America Bioresorbable Scaffolds, by Country USD Million (2023-2028)
  • Table 368. North America Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 369. North America Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 370. North America Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 371. North America Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 372. United States Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 373. United States Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 374. United States Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 375. United States Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 376. Canada Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 377. Canada Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 378. Canada Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 379. Canada Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 380. Mexico Bioresorbable Scaffolds, by Type USD Million (2023-2028)
  • Table 381. Mexico Bioresorbable Scaffolds, by Application USD Million (2023-2028)
  • Table 382. Mexico Bioresorbable Scaffolds, by Material USD Million (2023-2028)
  • Table 383. Mexico Bioresorbable Scaffolds, by End User USD Million (2023-2028)
  • Table 384. Bioresorbable Scaffolds Sales: by Type(K Units)
  • Table 385. Bioresorbable Scaffolds Sales Synthetic , by Region K Units (2023-2028)
  • Table 386. Bioresorbable Scaffolds Sales Biological , by Region K Units (2023-2028)
  • Table 387. Bioresorbable Scaffolds Sales: by Application(K Units)
  • Table 388. Bioresorbable Scaffolds Sales Coronary Artery Stents , by Region K Units (2023-2028)
  • Table 389. Bioresorbable Scaffolds Sales Peripheral Artery Stents , by Region K Units (2023-2028)
  • Table 390. Bioresorbable Scaffolds Sales Others , by Region K Units (2023-2028)
  • Table 391. Bioresorbable Scaffolds Sales: by Material(K Units)
  • Table 392. Bioresorbable Scaffolds Sales Metal-based Bioresorbable Scaffold , by Region K Units (2023-2028)
  • Table 393. Bioresorbable Scaffolds Sales Polymer-based Bioresorbable Scaffold , by Region K Units (2023-2028)
  • Table 394. Bioresorbable Scaffolds Sales: by End User(K Units)
  • Table 395. Bioresorbable Scaffolds Sales Hospitals , by Region K Units (2023-2028)
  • Table 396. Bioresorbable Scaffolds Sales Ambulatory Surgical Centers , by Region K Units (2023-2028)
  • Table 397. Bioresorbable Scaffolds Sales Cardiac Centers , by Region K Units (2023-2028)
  • Table 398. Bioresorbable Scaffolds Sales Others , by Region K Units (2023-2028)
  • Table 399. South America Bioresorbable Scaffolds Sales, by Country K Units (2023-2028)
  • Table 400. South America Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 401. South America Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 402. South America Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 403. South America Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 404. Brazil Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 405. Brazil Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 406. Brazil Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 407. Brazil Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 408. Argentina Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 409. Argentina Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 410. Argentina Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 411. Argentina Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 412. Rest of South America Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 413. Rest of South America Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 414. Rest of South America Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 415. Rest of South America Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 416. Asia Pacific Bioresorbable Scaffolds Sales, by Country K Units (2023-2028)
  • Table 417. Asia Pacific Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 418. Asia Pacific Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 419. Asia Pacific Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 420. Asia Pacific Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 421. China Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 422. China Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 423. China Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 424. China Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 425. Japan Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 426. Japan Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 427. Japan Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 428. Japan Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 429. India Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 430. India Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 431. India Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 432. India Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 433. South Korea Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 434. South Korea Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 435. South Korea Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 436. South Korea Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 437. Taiwan Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 438. Taiwan Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 439. Taiwan Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 440. Taiwan Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 441. Australia Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 442. Australia Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 443. Australia Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 444. Australia Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 445. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 446. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 447. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 448. Rest of Asia-Pacific Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 449. Europe Bioresorbable Scaffolds Sales, by Country K Units (2023-2028)
  • Table 450. Europe Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 451. Europe Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 452. Europe Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 453. Europe Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 454. Germany Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 455. Germany Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 456. Germany Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 457. Germany Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 458. France Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 459. France Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 460. France Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 461. France Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 462. Italy Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 463. Italy Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 464. Italy Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 465. Italy Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 466. United Kingdom Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 467. United Kingdom Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 468. United Kingdom Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 469. United Kingdom Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 470. Netherlands Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 471. Netherlands Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 472. Netherlands Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 473. Netherlands Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 474. Rest of Europe Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 475. Rest of Europe Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 476. Rest of Europe Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 477. Rest of Europe Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 478. MEA Bioresorbable Scaffolds Sales, by Country K Units (2023-2028)
  • Table 479. MEA Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 480. MEA Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 481. MEA Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 482. MEA Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 483. Middle East Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 484. Middle East Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 485. Middle East Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 486. Middle East Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 487. Africa Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 488. Africa Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 489. Africa Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 490. Africa Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 491. North America Bioresorbable Scaffolds Sales, by Country K Units (2023-2028)
  • Table 492. North America Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 493. North America Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 494. North America Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 495. North America Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 496. United States Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 497. United States Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 498. United States Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 499. United States Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 500. Canada Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 501. Canada Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 502. Canada Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 503. Canada Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 504. Mexico Bioresorbable Scaffolds Sales, by Type K Units (2023-2028)
  • Table 505. Mexico Bioresorbable Scaffolds Sales, by Application K Units (2023-2028)
  • Table 506. Mexico Bioresorbable Scaffolds Sales, by Material K Units (2023-2028)
  • Table 507. Mexico Bioresorbable Scaffolds Sales, by End User K Units (2023-2028)
  • Table 508. Bioresorbable Scaffolds: by Type(USD/Units)
  • Table 509. Research Programs/Design for This Report
  • Table 510. Key Data Information from Secondary Sources
  • Table 511. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bioresorbable Scaffolds: by Type USD Million (2017-2022)
  • Figure 5. Global Bioresorbable Scaffolds: by Application USD Million (2017-2022)
  • Figure 6. Global Bioresorbable Scaffolds: by Material USD Million (2017-2022)
  • Figure 7. Global Bioresorbable Scaffolds: by End User USD Million (2017-2022)
  • Figure 8. South America Bioresorbable Scaffolds Share (%), by Country
  • Figure 9. Asia Pacific Bioresorbable Scaffolds Share (%), by Country
  • Figure 10. Europe Bioresorbable Scaffolds Share (%), by Country
  • Figure 11. MEA Bioresorbable Scaffolds Share (%), by Country
  • Figure 12. North America Bioresorbable Scaffolds Share (%), by Country
  • Figure 13. Global Bioresorbable Scaffolds: by Type K Units (2017-2022)
  • Figure 14. Global Bioresorbable Scaffolds: by Application K Units (2017-2022)
  • Figure 15. Global Bioresorbable Scaffolds: by Material K Units (2017-2022)
  • Figure 16. Global Bioresorbable Scaffolds: by End User K Units (2017-2022)
  • Figure 17. South America Bioresorbable Scaffolds Share (%), by Country
  • Figure 18. Asia Pacific Bioresorbable Scaffolds Share (%), by Country
  • Figure 19. Europe Bioresorbable Scaffolds Share (%), by Country
  • Figure 20. MEA Bioresorbable Scaffolds Share (%), by Country
  • Figure 21. North America Bioresorbable Scaffolds Share (%), by Country
  • Figure 22. Global Bioresorbable Scaffolds: by Type USD/Units (2017-2022)
  • Figure 23. Global Bioresorbable Scaffolds share by Players 2022 (%)
  • Figure 24. Global Bioresorbable Scaffolds share by Players (Top 3) 2022(%)
  • Figure 25. Global Bioresorbable Scaffolds share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. 480 Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 28. 480 Biomedical (United States) Revenue: by Geography 2022
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 31. Amaranth Medical Inc. (Singapore) Revenue, Net Income and Gross profit
  • Figure 32. Amaranth Medical Inc. (Singapore) Revenue: by Geography 2022
  • Figure 33. Arterial Remodeling Technologies (France) Revenue, Net Income and Gross profit
  • Figure 34. Arterial Remodeling Technologies (France) Revenue: by Geography 2022
  • Figure 35. Arterius Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Arterius Limited (United Kingdom) Revenue: by Geography 2022
  • Figure 37. BIOTRONIK (Germany) Revenue, Net Income and Gross profit
  • Figure 38. BIOTRONIK (Germany) Revenue: by Geography 2022
  • Figure 39. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 41. Elixir Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Elixir Medical Corporation (United States) Revenue: by Geography 2022
  • Figure 43. HangZhou HuaAn Biotechnology Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 44. HangZhou HuaAn Biotechnology Co. Ltd. (China) Revenue: by Geography 2022
  • Figure 45. KYOTO MEDICAL PLANNING Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 46. KYOTO MEDICAL PLANNING Co. Ltd. (Japan) Revenue: by Geography 2022
  • Figure 47. Global Bioresorbable Scaffolds: by Type USD Million (2023-2028)
  • Figure 48. Global Bioresorbable Scaffolds: by Application USD Million (2023-2028)
  • Figure 49. Global Bioresorbable Scaffolds: by Material USD Million (2023-2028)
  • Figure 50. Global Bioresorbable Scaffolds: by End User USD Million (2023-2028)
  • Figure 51. South America Bioresorbable Scaffolds Share (%), by Country
  • Figure 52. Asia Pacific Bioresorbable Scaffolds Share (%), by Country
  • Figure 53. Europe Bioresorbable Scaffolds Share (%), by Country
  • Figure 54. MEA Bioresorbable Scaffolds Share (%), by Country
  • Figure 55. North America Bioresorbable Scaffolds Share (%), by Country
  • Figure 56. Global Bioresorbable Scaffolds: by Type K Units (2023-2028)
  • Figure 57. Global Bioresorbable Scaffolds: by Application K Units (2023-2028)
  • Figure 58. Global Bioresorbable Scaffolds: by Material K Units (2023-2028)
  • Figure 59. Global Bioresorbable Scaffolds: by End User K Units (2023-2028)
  • Figure 60. South America Bioresorbable Scaffolds Share (%), by Country
  • Figure 61. Asia Pacific Bioresorbable Scaffolds Share (%), by Country
  • Figure 62. Europe Bioresorbable Scaffolds Share (%), by Country
  • Figure 63. MEA Bioresorbable Scaffolds Share (%), by Country
  • Figure 64. North America Bioresorbable Scaffolds Share (%), by Country
  • Figure 65. Global Bioresorbable Scaffolds: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • 480 Biomedical (United States)
  • Abbott Laboratories (United States)
  • Amaranth Medical Inc. (Singapore)
  • Arterial Remodeling Technologies (France)
  • Arterius Limited (United Kingdom)
  • BIOTRONIK (Germany)
  • Boston Scientific Corporation (United States)
  • Elixir Medical Corporation (United States)
  • HangZhou HuaAn Biotechnology Co. Ltd. (China)
  • KYOTO MEDICAL PLANNING Co. Ltd. (Japan)
Additional players considered in the study are as follows:
Lepu Medical Technology (Beijing) Co., Ltd. (China) , Lifetech Scientific (Shenzhen) Co. Ltd (China) , Manli Cardiology Ltd. (United States) , Meril Life Sciences Pvt. Ltd. (India) , OrbusNeich (hong Kong) , Qualimed S.A.S. (France) , REVA Medical Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 210 Pages 74 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bioresorbable Scaffolds Quantitative research analysis
Global Bioresorbable Scaffolds Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as 480 Biomedical (United States), Abbott Laboratories (United States), Amaranth Medical Inc. (Singapore), Arterial Remodeling Technologies (France), Arterius Limited (United Kingdom), BIOTRONIK (Germany), Boston Scientific Corporation (United States), Elixir Medical Corporation (United States), HangZhou HuaAn Biotechnology Co. Ltd. (China) and KYOTO MEDICAL PLANNING Co. Ltd. (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Introduction Preference for Vascular Graft Devices for Angioplasty and Coronary Artery Diseases " is seen as one of major influencing trends for Bioresorbable Scaffolds Market during projected period 2022-2028.
The Bioresorbable Scaffolds market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Bioresorbable Scaffolds Report?

Have a Query? Click Here

Other Related Reports

Blood Transfusion Devices Comprehensive Study by Type (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), Application (Blood Disorders, Autoimmune Disorders,...
$ 3650
Electrosurgical Generator Comprehensive Study by Type (Monopole Electrosurgical Generator, Bipolar Electrosurgical Generator, Vessel Sealing Generator), Application (Hospital & Clinics, Ambulatory Su...
$ 3650
Insulin Pen Comprehensive Study by Type (Disposable cartridge Insulin Pens, Reusable cartridge Insulin Pens), Application (Hospital, Diabetes Clinics/ Centers, Home) Players and Region - Global Marke...
$ 3500
Knee Reconstruction Devices Comprehensive Study by Type (Primary Implants Knee Reconstruction (Cement less, Cemented), Partial Implants Knee Reconstruction, Revision Implants Knee Reconstruction), Ap...
$ 3750
Medical Cyclotron Comprehensive Study by Type (Upto 15 MeV, 25 MeV-30 MeV, 35 MeV-60 MeV, More than 60 MeV), Application (Diagnostic and Treatment, Research and Development, Others), End-Users (Hospi...
$ 3450
Endotracheal Tubes Comprehensive Study by Type (Cuff, Uncuffed), Application (Laser Surgery, Head and Neck Surgery, Anesthesia, Others), End-Users (Hospital, Clinics, Ambulatory Surgical Centers), In...
$ 3450